EUVIMEDEUVIMED entdecken
Crossref

20‐Acetylsinularolide B (ASB) From Lobophytum crassum Exhibits Anticancer Activity In Vitro Through IGF1R/PI3K/AKT/mTOR Pathway

Yuanmin Chang, Shoumao Shen, Liting Zhang, Jianang Zeng, Jingyong Sun iD, Yue-Wei Guo, Ming-Zhi Su iD

Chemistry & Biodiversity · 2025-09 · 22 (9)

DOI: 10.1002/cbdv.202500114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 03.05.2025. Verfasst von Yuanmin Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China. Hauptthemen laut MEDLINE: Diterpenes, Antineoplastic Agents, Anthozoa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key R&D Program of Shandong Province, China, Shandong Laboratory Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As lung cancer remains the leading cause of cancer‐related deaths worldwide, the development of novel therapeutic drugs is essential. 20‐Acetylsinularolide B (ASB) is a diterpene isolated from marine soft coral Lobophytum crassum . Our previous studies demonstrated that ASB exhibits growth‐inhibitory effects on non–small cell lung cancer (NSCLC) cells. This study employed network pharmacology to predict ASB's potential targets in NSCLC treatment. The predicted target was validated using the cellular thermal shift assay (CETSA). In vitro anticancer activity was assessed through MTT and crystal violet assays for proliferation, along with Western blotting, cell cycle and apoptosis analysis, mitochondrial membrane potential, reactive oxygen species (ROS) levels, and nuclear morphology evaluation. Migration and invasion were evaluated using wound healing and Transwell assays. The results showed that ASB significantly arrests the cell cycle of H1299 cells at the G 2 /M phase by modulating the IGF1R/PI3K/AKT/mTOR signaling pathway, thereby inhibiting cell mitosis. Simultaneously, ASB promoted intracellular ROS production, reduced mitochondrial membrane potential, and ultimately induced cell apoptosis. In addition, ASB significantly inhibited the colony formation, migration, and invasion abilities of H1299 cells, which are closely associated with the function of the IGF1R target. These findings highlight the significant potential of ASB as a lead anticancer compound for NSCLC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesAntineoplastic AgentsAnthozoaHumansProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesCell ProliferationReceptor, IGF Type 1Signal TransductionApoptosisDrug Screening Assays, AntitumorReactive Oxygen SpeciesAnimalsMembrane Potential, MitochondrialCell Line, TumorCell MovementDose-Response Relationship, DrugStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

20‐acetylsinularolide Bapoptosisepithelial–mesenchymal transition (EMT)marine natural productnetwork pharmacologynon–small cell lung cancer (NSCLC)

Substanzen

Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesDiterpenesPhosphatidylinositol 3-KinasesAntineoplastic AgentsReceptor, IGF Type 1Reactive Oxygen SpeciesIGF1R protein, humanMTOR protein, human

Autor:innen und Institutionen

  • Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
  • School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
  • School of Pharmacy, Yancheng Teachers University, Yancheng, China.
  • School of Medicine, Shanghai University, Shanghai, China.

ORCID-Profile: Jingyong Sun, Ming-Zhi Su

Förderung

  • National Natural Science Foundation of China
  • Key R&D Program of Shandong Province, China
  • Shandong Laboratory Program
  • Natural Science Foundation of the Higher Education Institutions of Jiangsu Province
  • Basic research project of Guizhou University

Zitieren

APA

Chang, Y., Shen, S., Zhang, L., Zeng, J., Sun, J., Guo, Y. W., & Su, M. Z. (2025). 20‐Acetylsinularolide B (ASB) From Lobophytum crassum Exhibits Anticancer Activity In Vitro Through IGF1R/PI3K/AKT/mTOR Pathway. Chemistry & Biodiversity, 22(9). https://doi.org/10.1002/cbdv.202500114

Vancouver

Chang Y, Shen S, Zhang L, Zeng J, Sun J, Guo YW, et al. 20‐Acetylsinularolide B (ASB) From Lobophytum crassum Exhibits Anticancer Activity In Vitro Through IGF1R/PI3K/AKT/mTOR Pathway. Chemistry & Biodiversity. 2025;22(9). doi:10.1002/cbdv.202500114

BibTeX
@article{Chang2025,
  author = {Chang, Yuanmin and Shen, Shoumao and Zhang, Liting and Zeng, Jianang and Sun, Jingyong and Guo, Yue-Wei and Su, Ming-Zhi},
  title = {20‐Acetylsinularolide B (ASB) From Lobophytum crassum Exhibits Anticancer Activity In Vitro Through IGF1R/PI3K/AKT/mTOR Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  volume = {22},
  number = {9},
  doi = {10.1002/cbdv.202500114}
}
Kostenlos starten →